Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neurobiol Dis
2014 Oct 01;70:74-89. doi: 10.1016/j.nbd.2014.06.004.
Show Gene links
Show Anatomy links
The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus.
Rojas A
,
Gueorguieva P
,
Lelutiu N
,
Quan Y
,
Shaw R
,
Dingledine R
.
???displayArticle.abstract???
Prostaglandin E2 (PGE2) regulates membrane excitability, synaptic transmission, plasticity, and neuronal survival. The consequences of PGE2 release following seizures has been the subject of much study. Here we demonstrate that the prostaglandin E2 receptor 1 (EP1, or Ptger1) modulates native kainate receptors, a family of ionotropic glutamate receptors widely expressed throughout the central nervous system. Global ablation of the EP1 gene in mice (EP1-KO) had no effect on seizure threshold after kainate injection but reduced the likelihood to enter status epilepticus. EP1-KO mice that did experience typical status epilepticus had reduced hippocampal neurodegeneration and a blunted inflammatory response. Further studies with native prostanoid and kainate receptors in cultured cortical neurons, as well as with recombinant prostanoid and kainate receptors expressed in Xenopus oocytes, demonstrated that EP1 receptor activation potentiates heteromeric but not homomeric kainate receptors via a second messenger cascade involving phospholipase C, calcium and protein kinase C. Three critical GluK5 C-terminal serines underlie the potentiation of the GluK2/GluK5 receptor by EP1 activation. Taken together, these results indicate that EP1 receptor activation during seizures, through a protein kinase C pathway, increases the probability of kainic acid induced status epilepticus, and independently promotes hippocampal neurodegeneration and a broad inflammatory response.
Ahmad,
PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.
2013, Pubmed
Ahmad,
PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.
2013,
Pubmed
Ahmad,
Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage.
2006,
Pubmed
Ben-Ari,
A new model of focal status epilepticus: intra-amygdaloid application of kainic acid elicits repetitive secondarily generalized convulsive seizures.
1979,
Pubmed
Benveniste,
Subunit-dependent modulation of kainate receptors by muscarinic acetylcholine receptors.
2010,
Pubmed
,
Xenbase
Bettler,
Review: neurotransmitter receptors. II. AMPA and kainate receptors.
1995,
Pubmed
Borges,
Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model.
2003,
Pubmed
Breyer,
Functional and molecular aspects of renal prostaglandin receptors.
1996,
Pubmed
Chamberlain,
SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity.
2012,
Pubmed
Chen,
Protein tyrosine kinase-mediated potentiation of currents from cloned NMDA receptors.
1996,
Pubmed
,
Xenbase
Chen,
Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons.
2005,
Pubmed
Curras,
Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
1992,
Pubmed
,
Xenbase
Darstein,
Distribution of kainate receptor subunits at hippocampal mossy fiber synapses.
2003,
Pubmed
Fukumoto,
Prostanoid EP1 receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia.
2010,
Pubmed
Guan,
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.
2007,
Pubmed
Hellier,
Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy.
1998,
Pubmed
Huettner,
Kainate receptors and synaptic transmission.
2003,
Pubmed
Jiang,
Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
2013,
Pubmed
Jiang,
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.
2010,
Pubmed
Kamiya,
Kainate receptor-dependent presynaptic modulation and plasticity.
2002,
Pubmed
Kawano,
Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.
2006,
Pubmed
Konopacki,
Agonist-induced PKC phosphorylation regulates GluK2 SUMOylation and kainate receptor endocytosis.
2011,
Pubmed
Kornreich,
Identification of C-terminal domain residues involved in protein kinase A-mediated potentiation of kainate receptor subtype 6.
2007,
Pubmed
Köhr,
Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family.
1996,
Pubmed
Lerma,
Molecular physiology of kainate receptors.
2001,
Pubmed
Lerma,
Roles and rules of kainate receptors in synaptic transmission.
2003,
Pubmed
MacDonald,
G protein-coupled receptors control NMDARs and metaplasticity in the hippocampus.
2007,
Pubmed
Martin,
SUMOylation regulates kainate-receptor-mediated synaptic transmission.
2007,
Pubmed
Matsuoka,
Prostaglandin E receptor EP1 controls impulsive behavior under stress.
2005,
Pubmed
Mott,
Subunit-specific desensitization of heteromeric kainate receptors.
2010,
Pubmed
,
Xenbase
Nadler,
Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells.
1978,
Pubmed
Nasu-Nishimura,
Differential regulation of kainate receptor trafficking by phosphorylation of distinct sites on GluR6.
2010,
Pubmed
Pickering,
Palmitoylation of the GluR6 kainate receptor.
1995,
Pubmed
Pinheiro,
Kainate receptors.
2006,
Pubmed
Quan,
EP2 receptor signaling pathways regulate classical activation of microglia.
2013,
Pubmed
Racine,
Modification of seizure activity by electrical stimulation. II. Motor seizure.
1972,
Pubmed
Raymond,
Phosphorylation and modulation of recombinant GluR6 glutamate receptors by cAMP-dependent protein kinase.
1993,
Pubmed
Raymond,
Glutamate receptor modulation by protein phosphorylation.
1994,
Pubmed
Rojas,
Ionotropic glutamate receptors: regulation by G-protein-coupled receptors.
2013,
Pubmed
Rojas,
Activation of group I metabotropic glutamate receptors potentiates heteromeric kainate receptors.
2013,
Pubmed
,
Xenbase
Schmued,
Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration.
1997,
Pubmed
Serrano,
Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.
2011,
Pubmed
Sharma,
Kainic acid-induced F-344 rat model of mesial temporal lobe epilepsy: gene expression and canonical pathways.
2009,
Pubmed
Shimamura,
Prostaglandin E2 type 1 receptors contribute to neuronal apoptosis after transient forebrain ischemia.
2013,
Pubmed
Sperk,
Kainic acid induced seizures: neurochemical and histopathological changes.
1983,
Pubmed
Stock,
The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure.
2001,
Pubmed
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Traynelis,
Control of rat GluR6 glutamate receptor open probability by protein kinase A and calcineurin.
1997,
Pubmed
Wang,
Phosphorylation and modulation of a kainate receptor (GluR6) by cAMP-dependent protein kinase.
1993,
Pubmed
Wang,
Regulation of NMDA receptors by tyrosine kinases and phosphatases.
1994,
Pubmed
Wang,
Kainic acid-mediated excitotoxicity as a model for neurodegeneration.
2005,
Pubmed
Wilkinson,
Analysis of SUMO-1 modification of neuronal proteins containing consensus SUMOylation motifs.
2008,
Pubmed
Wilkinson,
Modification and movement: Phosphorylation and SUMOylation regulate endocytosis of GluK2-containing kainate receptors.
2012,
Pubmed
Zhen,
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
2012,
Pubmed
Zhu,
Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors.
2005,
Pubmed
